[EN] PIFITHRIN ANALOGUES AND METHODS OF TREATING RETT SYNDROME<br/>[FR] ANALOGUES DE PIFITHRINE ET MÉTHODES DE TRAITEMENT DU SYNDROME DE RETT
申请人:UNIV CALIFORNIA
公开号:WO2020247336A1
公开(公告)日:2020-12-10
Disclosed herein are Pifithrin compounds, methods of treating Rett Syndrome, brain fusion organoids comprising a fusion between a cerebral cortex (Cx) organoid and the ganglionic eminence (GE) organoid, one of which comprises, consists essentially of, or consists of neural cells having a loss of function mutation in the Methyl-CpG Binding Protein 2 (MECP2) gene, and methods of using the brain fusion organoid to screen for candidate compounds that treat, reduce, or inhibit the abnormal neural activities caused by MECP2 − mutations.
Inhibitors of Apoptosis in Lymphocytes: Synthesis and Biological Evaluation of Compounds Related to Pifithrin-α
作者:Sylvie D. Barchéchath、Rommel I. Tawatao、Maripat Corr、Dennis A. Carson、Howard B. Cottam
DOI:10.1021/jm0502034
日期:2005.10.1
39 were more protective than 39, while the aromatic analogues of 1 were not active. Compound 19 containing a pyrrolidinyl substituent on the phenyl ring provided potent antiapoptotic activity (EC50 of 1.31 microM compared to 4.16 microM for 1). Modification of aromatic 39 with a pyrrolidinyl para substituent (compound 60) enhanced the activity, lowering the EC50 to 0.35 microM. Also, 60 provided significant